AQUALITAS INC

Overview

AQUALITAS INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering PHASE 2 MULTICENTER RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY TO ASSESS THE SAFETY AND EFFICACY OF INHALED CANNABIS IN VETERANS FOR TREATMENT OF POSTTRAUMATIC STRESS DISORDER (PTSD).

Therapeutic areas

API / Drug Master Files

AQUALITAS INC holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PHASE 2 MULTICENTER RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY TO ASSESS THE SAFETY AND EFFICACY OF INHALED CANNABIS IN VETERANS FOR TREATMENT OF POSTTRAUMATIC STRESS DISORDER (PTSD)Active2024-04-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to AQUALITAS INC in our records. PharmaTek screens the full directory against live FDA enforcement data.